Surrey Heartlands

Joint Formulary & PAD

Aripiprazole - Schizophrenia and other psychoses

You are here : Home > Formulary Search > Aripiprazole - Schizophrenia and other psychoses

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Initiation by a SABP specialist and stabilisation for a minimum of 3 months before any request to transfer prescribing responsibility.

 

Status 2

Blue
Formulations :
  • Oro-dispersible tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
R
SPC
Restrictions / Comments :
Important

Reserve for patients who are unable to swallow tablets.

 

Status 3

Blue
Formulations :
  • Oral solution
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
R
SPC
Restrictions / Comments :
Important

Oro-dispersible tablets are more cost effectice than oral solution. Reserve oral solution for use in patients where the required dose is not available in an oro-dispersible form.

 

Status 4

Amber
Formulations :
  • Depot injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

One monthly or two monthly injecton schedule available

  • Monthly injection – Deltoid or gluteal muscle
  • Injection every 2 months – Gluteal muscle only

For administration under the shared-care LCS when prescribed in Primary Care.

Documents :
 
Shared Care
Aripiprazole Depot Injection - Shared Care - April 25
 

Status 5

Red
Formulations :
  • Depot injection
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
SPC
Restrictions / Comments :
Important

Where there is no LCS in place, the prescribing responsibility remains with SABP.

Secondary Care may prescribe for in-patients (on the instruction of a SABP specialist) and prescribing continued by SABP after discharge.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Aripiprazole
Indication :
Schizophrenia and other psychoses
Group Name :
Keywords :
antipsychotics, depot antipsychotics, LAI
Brand Names Include :
Abilify, Abilify Maintena
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Traffic Light Entries :
5

Other Indications

Below are listed other indications that Aripiprazole is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Schizophrenia and other psychoses.

Committee Recommendations (3)

02 Jul 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Follow link to Shared Care Principles and Communication letters Shared Care principles and Communication letters

02 Apr 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integated Care system Area Prescribing Committee recommends the administration of depot antipsychotic injections under an AMBER shared care agreement for practices that have signed up to the agreed locally commissioned service (LCS). The AMBER shared care includes a monthly injection schedule and a schedule for injections every 2 months.
 

Surrey Heartlands ICB have developed the LCS to enable stable patients with schizophrenia to be prescribed and administered these injections through their primary care prescriber (GP). 

If a practice has not signed up to the LCS the drug remains as RED status and prescriptions will be issued by the provider.

03 May 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
GENERIC Aripiprazole has been considered by the PCN and has been assigned a BLUE traffic light status.

NOTE - the branded product, Abilify, was considered BLACK at the PCN in May 2017.